BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 36902473)

  • 1. Polyoxometalates Impact as Anticancer Agents.
    Carvalho F; Aureliano M
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ni/Mn-Complex-Tethered Tetranuclear Polyoxovanadates: Crystal Structure and Inhibitory Activity on Human Hepatocellular Carcinoma (HepG-2).
    Shi F; Chen Y; Dong C; Wang J; Song C; Zhang Y; Li Z; Huang X
    Molecules; 2023 Sep; 28(19):. PubMed ID: 37836686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organo-functionalized polyoxovanadates: crystal architecture and property aspects.
    Wang J; Liu X; Du Z; Xu Y
    Dalton Trans; 2021 Jun; 50(23):7871-7886. PubMed ID: 34008655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyoxometalates as antitumor agents: Bioactivity of a new polyoxometalate with copper on a human osteosarcoma model.
    León IE; Porro V; Astrada S; Egusquiza MG; Cabello CI; Bollati-Fogolin M; Etcheverry SB
    Chem Biol Interact; 2014 Oct; 222():87-96. PubMed ID: 25451568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rare Earth Polyoxometalates.
    Boskovic C
    Acc Chem Res; 2017 Sep; 50(9):2205-2214. PubMed ID: 28872827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights into organic-inorganic hybrid molecular materials: organoimido functionalized polyoxomolybdates.
    Pardiwala A; Kumar S; Jangir R
    Dalton Trans; 2022 Mar; 51(13):4945-4975. PubMed ID: 35246674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polyoxometalates in Biomedicine: Update and Overview.
    Čolović MB; Lacković M; Lalatović J; Mougharbel AS; Kortz U; Krstić DZ
    Curr Med Chem; 2020; 27(3):362-379. PubMed ID: 31453779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial Activity of Polyoxometalates Against
    Gumerova NI; Al-Sayed E; Krivosudský L; Čipčić-Paljetak H; Verbanac D; Rompel A
    Front Chem; 2018; 6():336. PubMed ID: 30155460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives.
    Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N
    Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Hetero-Polyoxovanadates and Their Solution Chemistry Analyzed by Electrospray Ionization Mass Spectrometry.
    Warzok U; Mahnke LK; Bensch W
    Chemistry; 2019 Jan; 25(6):1405-1419. PubMed ID: 30079971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comprehensive comparison of transition-metal and actinyl polyoxometalates.
    Nyman M; Burns PC
    Chem Soc Rev; 2012 Nov; 41(22):7354-67. PubMed ID: 22695929
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANTICANCER ACTIVITY OF 5, 7-DIMETHOXYFLAVONE AGAINST LIVER CANCER CELL LINE HEPG2 INVOLVES APOPTOSIS, ROS GENERATION AND CELL CYCLE ARREST.
    Li H; Zhang X; Wang W
    Afr J Tradit Complement Altern Med; 2017; 14(4):213-220. PubMed ID: 28638884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transition metal substituted sandwich-type polyoxometalates with a strong metal-C (imidazole) bond as anticancer agents.
    Zhao H; Tao L; Zhang F; Zhang Y; Liu Y; Xu H; Diao G; Ni L
    Chem Commun (Camb); 2019 Jan; 55(8):1096-1099. PubMed ID: 30620027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular signature of polyoxometalates in electron transport of silicon-based molecular junctions.
    Laurans M; Dalla Francesca K; Volatron F; Izzet G; Guerin D; Vuillaume D; Lenfant S; Proust A
    Nanoscale; 2018 Sep; 10(36):17156-17165. PubMed ID: 30187072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bithionol inhibits ovarian cancer cell growth in vitro - studies on mechanism(s) of action.
    Ayyagari VN; Brard L
    BMC Cancer; 2014 Feb; 14():61. PubMed ID: 24495391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyoxometalates for bifunctional applications: Catalytic dye degradation and anticancer activity.
    Ong BC; Lim HK; Tay CY; Lim TT; Dong Z
    Chemosphere; 2022 Jan; 286(Pt 3):131869. PubMed ID: 34418655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polyoxometalates as potent and selective inhibitors of alkaline phosphatases with profound anticancer and amoebicidal activities.
    Raza R; Matin A; Sarwar S; Barsukova-Stuckart M; Ibrahim M; Kortz U; Iqbal J
    Dalton Trans; 2012 Dec; 41(47):14329-36. PubMed ID: 23044850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel synthetic analogs of diallyl disulfide triggers cell cycle arrest and apoptosis via ROS generation in MIA PaCa-2 cells.
    Saini V; Manral A; Arora R; Meena P; Gusain S; Saluja D; Tiwari M
    Pharmacol Rep; 2017 Aug; 69(4):813-821. PubMed ID: 28591670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyoxometalates: Study of inhibitory kinetics and mechanism against α-glucosidase.
    Chi G; Wang L; Chen B; Li J; Hu J; Liu S; Zhao M; Ding X; Li Y
    J Inorg Biochem; 2019 Oct; 199():110784. PubMed ID: 31351380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functionalized polyoxometalates with covalently linked bisphosphonate, N-donor or carboxylate ligands: from electrocatalytic to optical properties.
    Dolbecq A; Mialane P; Sécheresse F; Keita B; Nadjo L
    Chem Commun (Camb); 2012 Aug; 48(67):8299-316. PubMed ID: 22763503
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.